The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-4 of 4 articles
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study
Bayard Y-L,
Omran H,
Neuzil P,
Thuesen L,
Pichler M,
Rowland E,
Ramondo A,
Ruzyllo W,
Budts W,
Montalescot G,
Brugada P,
Serruys P,
Vahanian A,
Piéchaud JF,
Bartorelli A,
Marco J,
Probst P,
Kuck K,
Ostermayer S,
Büscheck F,
Fischer E,
Leetz M,
Sievert H
June 30, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)
Lang I,
Forman S,
Maggioni A,
Ruzyllo W,
Renkin J,
Vozzi C,
Steg G,
Hernandez-Garcia J,
Zmudka K,
Jimenez-Navarro M,
Sopko G,
Lamas G,
Hochman J
November 15, 2009 | 10.4244/EIJV5I5A98
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)
Routledge H,
Lefèvre T,
Colombo A,
Oldroyd K,
Hamm C,
Guagliumi G,
von Scheidt W,
Guetta V,
Ruzyllo W,
Wittebols K,
Goedhart D,
Serruys P
June 30, 2009
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023